IFNG and in situ carcinoma: The CRISPR-Cas9 control cells expressed SA-β-gal when exposed to IFN-γ/TNF and did not restart their exponential growth following IFN-γ/TNF withdrawal, showing that they were susceptible to CIS (Fig. 3c).